Regenerative therapies in electrophysiology and pacing: introducing the next steps

J Interv Card Electrophysiol. 2011 Jun;31(1):3-16. doi: 10.1007/s10840-010-9529-x. Epub 2010 Dec 16.


The morbidity and mortality of cardiac arrhythmias are major international health concerns. Drug and device therapies have made inroads but alternative approaches are still being sought. For example, gene and cell therapies have been explored for treatment of brady- and tachyarrhythmias, and proof of concept has been obtained for both biological pacing in the setting of heart block and gene therapy for ventricular tachycardias. This paper reviews the state of the art developments with regard to gene and cell therapies for cardiac arrhythmias and discusses next steps.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Arrhythmias, Cardiac / therapy*
  • Bradycardia / therapy
  • Cardiac Electrophysiology / trends*
  • Cardiac Pacing, Artificial / trends*
  • Cell- and Tissue-Based Therapy*
  • Genetic Therapy*
  • Humans
  • Tachycardia / therapy